Evidence map›Paper›PMID 26569394›Full record

ArticlePloS one2015

CCK Response Deficiency in Synphilin-1 Transgenic Mice.

Wanli W Smith, Megan Smith, Dejun Yang, Pique P Choi, Alexander Moghadam, Tianxia Li, Timothy H Moran

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact, top 84% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Wanli W SmithDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, United States of America.
Megan SmithDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Dejun YangDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, United States of America.
Pique P ChoiDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Alexander MoghadamDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Tianxia LiDepartment of Pharmaceutical Sciences, University of Maryland School of Pharmacy, Baltimore, Maryland, United States of America.
Timothy H MoranDepartment of Psychiatry, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.
Johns Hopkins University · USUniversity of Maryland, Baltimore · USJohns Hopkins Medicine · US

Funding

Synphilin-1 and ObesityR01DK083410 · NIDDK · UNIVERSITY OF MARYLAND BALTIMORE · PI SMITH, WANLI W · 2010 to 2014
$1.7M
NIDDK NIH HHS DK083410NIDDK NIH HHS R01 DK083410
6 · The paper itself

Abstract

Previously, we have identified a novel role for the cytoplasmic protein, synphilin-1(SP1), in the controls of food intake and body weight in both mice and Drosophila. Ubiquitous overexpression of human SP1 in brain neurons in transgenic mice results in hyperphagia expressed as an increase in meal size. However, the mechanisms underlying this action of SP1 remain to be determined. Here we investigate a potential role for altered gut feedback signaling in the effects of SP1 on food intake. We examined responses to peripheral administration of cholecytokinin (CCK), amylin, and the glucagon like peptide-1 (GLP-1) receptor agonist, exendin-4. Intraperitoneal administration of CCK at doses ranging from 1-10 nmol/kg significantly reduced glucose intake in wild type (WT) mice, but failed to affect intake in SP1 transgenic mice. Moreover, there was a significant attenuation of CCK-induced c-Fos expression in the dorsal vagal complex in SP1 transgenic mice. In contrast, WT and SP1 transgenic mice were similarly responsive to both amylin and exendin-4 treatment. These studies demonstrate that SP1 results in a CCK response deficiency that may contribute to the increased meal size and overall hyperphagia in synphillin-1 transgenic mice.

Indexed as

Gene Expression RegulationAnimalsBody WeightBrainCarrier ProteinsCholecystokininCytoplasmEatingExenatideFeeding BehaviorFemaleGenotypeGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor AgonistsHumansHyperphagiaCarrier ProteinsCholecystokininExenatideGlucagon-Like Peptide 1Glucagon-Like Peptide-1 Receptor AgonistsIntracellular Signaling Peptides and ProteinsIslet Amyloid PolypeptideNerve Tissue ProteinsPeptidesProto-Oncogene Proteins c-fosSNCAIP protein, humanSncaip protein, mouseVenoms

Identifiers

PMID26569394
PMCPMC4646498
OpenAlexW2268826049

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.